Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 236
7
Diseases
31
Unique genes
0.236
Avg. similarity score
Alpha-1 antitrypsin deficiency
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Alpha-1 antitrypsin deficiency
Beriberi
Gastro-entero-pancreatic neuroendocrine tumor
Panniculitis
Thiamine deficiency
Asbestosis
immunodeficiency 63 with lymphoproliferation and autoimmunity
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Alpha-1 antitrypsin deficiency | 5 | 5 | 1 |
| Beriberi | 5 | 5 | 1 |
| Gastro-entero-pancreatic neuroendocrine tumor | 5 | 5 | 15 |
| Panniculitis | 5 | 5 | 1 |
| Thiamine deficiency | 5 | 5 | 1 |
| Asbestosis | 4 | 4 | 17 |
| immunodeficiency 63 with lymphoproliferation and autoimmunity | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SERPINA1 | 6 / 7 | Alpha-1 antitrypsin deficiency, Asbestosis, Beriberi, Gastro-entero-pancreatic neuroendocrine tumor and 2 more |
| IL2RB | 2 / 7 | Gastro-entero-pancreatic neuroendocrine tumor, immunodeficiency 63 with lymphoproliferation and autoimmunity |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Amoebiasis | KEGG | 6 / 103 | 22.6× | 2.13e-7 | 1.26e-5 ✓ sig. |
| Lipid and atherosclerosis | KEGG | 7 / 216 | 12.6× | 1.01e-6 | 4.90e-5 ✓ sig. |
| Pertussis | KEGG | 5 / 78 | 24.8× | 1.51e-6 | 6.96e-5 ✓ sig. |
| Interleukin-10 signaling | Reactome | 4 / 47 | 33.0× | 5.99e-6 | 2.20e-4 ✓ sig. |
| Interleukin-4 and Interleukin-13 signaling | Reactome | 5 / 108 | 17.9× | 7.56e-6 | 2.65e-4 ✓ sig. |
| Inflammatory bowel disease | KEGG | 4 / 66 | 23.5× | 2.34e-5 | 6.79e-4 ✓ sig. |
| ATF6 (ATF6-alpha) activates chaperones | Reactome | 2 / 4 | 194× | 3.86e-5 | 1.03e-3 ✓ sig. |
| Leishmaniasis | KEGG | 4 / 78 | 19.9× | 4.53e-5 | 1.18e-3 ✓ sig. |
| RUNX3 Regulates Immune Response and Cell Migration | Reactome | 2 / 5 | 155× | 6.42e-5 | 1.56e-3 ✓ sig. |
| Th1 and Th2 cell differentiation | KEGG | 4 / 93 | 16.7× | 9.03e-5 | 2.07e-3 ✓ sig. |
| Tuberculosis | KEGG | 5 / 181 | 10.7× | 9.09e-5 | 2.08e-3 ✓ sig. |
| African trypanosomiasis | KEGG | 3 / 37 | 31.4× | 1.14e-4 | 2.49e-3 ✓ sig. |
| Allograft rejection | KEGG | 3 / 39 | 29.8× | 1.34e-4 | 2.83e-3 ✓ sig. |
| Chagas disease | KEGG | 4 / 103 | 15.0× | 1.34e-4 | 2.85e-3 ✓ sig. |
| C-type lectin receptor signaling pathway | KEGG | 4 / 105 | 14.8× | 1.45e-4 | 3.03e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| cellular response to lipopolysaccharide | GO:0071222 | 7 / 187 | 22.6× | 1.93e-8 | 3.02e-6 ✓ sig. |
| positive regulation of transcription by RNA polymerase II | GO:0045944 | 13 / 1,208 | 6.5× | 2.22e-8 | 3.42e-6 ✓ sig. |
| positive regulation of immunoglobulin production | GO:0002639 | 4 / 33 | 73.1× | 2.45e-7 | 2.57e-5 ✓ sig. |
| cell redox homeostasis | GO:0045454 | 4 / 44 | 54.8× | 8.03e-7 | 6.94e-5 ✓ sig. |
| positive regulation of heterotypic cell-cell adhesion | GO:0034116 | 3 / 13 | 139× | 1.17e-6 | 9.40e-5 ✓ sig. |
| positive regulation of miRNA transcription | GO:1902895 | 4 / 56 | 43.1× | 2.14e-6 | 1.52e-4 ✓ sig. |
| humoral immune response | GO:0006959 | 4 / 58 | 41.6× | 2.47e-6 | 1.71e-4 ✓ sig. |
| chronic inflammatory response to antigenic stimulus | GO:0002439 | 2 / 2 | 603× | 2.66e-6 | 1.81e-4 ✓ sig. |
| positive regulation of DNA-templated transcription | GO:0045893 | 9 / 778 | 7.0× | 3.17e-6 | 2.09e-4 ✓ sig. |
| positive regulation of interleukin-8 production | GO:0032757 | 4 / 65 | 37.1× | 3.91e-6 | 2.47e-4 ✓ sig. |
| positive regulation of non-canonical NF-kappaB signal transduction | GO:1901224 | 4 / 66 | 36.5× | 4.16e-6 | 2.59e-4 ✓ sig. |
| response to lipopolysaccharide | GO:0032496 | 5 / 161 | 18.7× | 6.32e-6 | 3.62e-4 ✓ sig. |
| regulation of ATF6-mediated unfolded protein response | GO:1903891 | 2 / 3 | 402× | 7.98e-6 | 4.37e-4 ✓ sig. |
| positive regulation of T cell mediated immunity | GO:0002711 | 2 / 3 | 402× | 7.98e-6 | 4.37e-4 ✓ sig. |
| positive regulation of cytokine production | GO:0001819 | 4 / 81 | 29.8× | 9.43e-6 | 4.99e-4 ✓ sig. |